What are the synergies between mylan and king


Assignment: Cases in Financial Decision-Making, Section

Case Study: Mylan Laboratories' Proposed Merger with King Pharmaceutical.

Suggested Assignment Questions:

1. Is the merger between Mylan and King a "good deal?" If so, for whom?

2. What does the market's immediate reaction to the merger proposal indicate about the deal?

3. Does the deal create any value overall? How are the gains from the deal-if any-distributed?

4. What are the synergies between Mylan and King? Who is gaining from these synergies? What are the risks to the synergies?

5. Is Mylan overpaying for King? If Mylan is willing to offer stock to buy King what does that suggest about the value of its stock?

6. Why does King's share price settle at less than 0.9 times Mylan's price? How can we infer the probability of the deal going through from the change in market prices over time?

7. What is Carl Icahn's motivation behind opposition to the merger? How Can Perry Capital counter Icahn's influence at Mylan? What are Perry's options and obstacles?

8. How do you reconcile Perry's apparent conflict of interest between holding positions in both Mylan and King shares simultaneously? Is there a moral hazard?

9. Do you approve of Perry's use of derivatives to hedge their risk expo.

Format your assignment according to the following formatting requirements:

1. The answer should be typed, double spaced, using Times New Roman font (size 12), with one-inch margins on all sides.

2. The response also include a cover page containing the title of the assignment, the student's name, the course title, and the date. The cover page is not included in the required page length.

3. Also Include a reference page. The Citations and references should follow APA format. The reference page is not included in the required page length.

Solution Preview :

Prepared by a verified Expert
Financial Management: What are the synergies between mylan and king
Reference No:- TGS02970566

Now Priced at $60 (50% Discount)

Recommended (94%)

Rated (4.6/5)